Managing patients with cardiorenal metabolic disease An overview of the pathophysiology of cardiorenal metabolic disease, medication optimisation strategies and the role of the pharmacist in medication management and patient education.…
‘Life-threatening condition’ added to Mounjaro patient information leaflet Manufacturer of Mounjaro, Eli Lilly has added more detail to the list of the drug's 'possible side effects'.…
Mounjaro health benefits found to reverse one year after stopping drug Researchers said their findings “underscore the importance of continued obesity treatment”.…
Health news round-up: men’s health, AMR and nuclear fuel turned cancer drug A weekly summary of important developments in health news that you may have missed.…
Oral insulin found to delay onset of type 1 diabetes in children Researchers found that the progression to type 1 diabetes mellitus was around 50% slower in infants genetically at risk of the disease who received oral insulin for three years compared to the placebo group.…
How safe are GLP-1s? As the use of weight-loss drugs continues to increase, there has been a rise in documented side effects. But what are the serious and unwanted effects of these drugs, and is Yellow Card reporting capturing enough information?…
Health news round-up: Vaccines, male contraception and medicines mix-ups Senior clinical reporter Joanna Robertson summarises some important developments in health news you may have missed.…
Health news round-up: mosquitoes, new HIV guidelines and research into cannabis and psilocybin Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
Beyond GLP-1: the next wave of weight-loss medication innovation From agonists and antagonists to ultrasound therapy, an in-depth look at the drug development pipeline has highlighted several promising new potential weight-loss medicines.…
Health news round-up: diabetes and weight-loss news from EASD Senior clinical reporter Joanna Robertson summarises clinical trial results from the European Association for the Study of Diabetes conference in Vienna.…
